TL;DR
This study investigates the potential of Lentinan (LNT), a natural compound, to reduce SARS-CoV-2 transmission. Researchers found that LNT treatment significantly lowered the aerosol transmission rate in golden hamsters and reduced viral loads in their respiratory systems, suggesting LNT could be a promising therapeutic agent for COVID-19 by altering the characteristics of exhaled viral aerosols.
What Problem Does This Paper Address?
The rapid global spread of SARS-CoV-2 is largely attributed to its efficient transmission via the aerosol route. Individuals infected with COVID-19, particularly with newer variants like Omicron, can exhale millions of virus particles per hour, even weeks after symptom onset. This sustained emission of infectious aerosols poses a significant challenge for public health interventions. The paper addresses the critical need for effective agents that can inhibit the emission of SARS-CoV-2 aerosols from infected individuals, thereby reducing transmission risk.
Methods
The study utilized a golden hamster model, known for its susceptibility to SARS-CoV-2 and its ability to mimic human disease progression and aerosol transmission.
- Viral Inoculation and Treatment: Hamsters were intranasally inoculated with SARS-CoV-2. A treatment group received daily oral gavage of Lentinan (LNT) at 20 mg/kg for five consecutive days, while a control group received a placebo (PBS).
- Viral Load Assessment: Viral titers in nasal washes and respiratory tissues (nasal turbinates, trachea, lungs) were quantified using TCID50 assays.
- Exhaled Aerosol Collection and Analysis: An Andersen-6 sampler was used to collect exhaled aerosols from hamsters. These samples were analyzed for viral RNA quantification (qRT-PCR) and the presence of infectious virus by inoculation into Vero E6 cells. The sampler fractionated aerosols by aerodynamic diameter (0.65–7.0 µm and >7.0 µm).
- Transmission Studies: In a separate experiment, donor hamsters were housed adjacent to naïve recipient hamsters to assess airborne transmission efficiency.
- Statistical Analysis: Standard statistical methods, including one-way ANOVA and the Student-Newman–Keuls (SNK) method, were employed to analyze the data.
Datasets
Not discussed in the paper. The study primarily relies on experimental data generated from animal models and laboratory assays.
Key Insights and Ideas
- LNT as an Aerosol Transmission Blocker: The most striking finding is LNT's ability to dramatically reduce the aerosol transmission rate of SARS-CoV-2 between hamsters, from 100% in the control group to 44.4% in the LNT-treated group. This suggests LNT directly impacts the mechanisms of viral spread via aerosols.
- Altering Aerosol Characteristics: LNT treatment led to a significant decrease in the amount of exhaled virus aerosols, particularly those with smaller aerodynamic diameters (<5 µm). This implies LNT might alter the physical properties of the aerosols, making them less likely to remain airborne or infectious.
- Dual Action: Reducing Viral Load and Infectivity: The study observed reduced viral loads in the respiratory tracts of LNT-treated hamsters, which likely contributes to the decreased aerosol shedding. Furthermore, the detection of infectious virus in smaller aerosol particles was significantly reduced in the LNT group, indicating a direct impact on viral infectivity within these aerosols.
- Potential for Broader Antiviral Mechanisms: While the study focuses on aerosol transmission, the observed reduction in viral loads and inflammatory markers (mentioned in the discussion) hints at broader antiviral and immunomodulatory effects of LNT, consistent with its known properties.
Key Results
- Transmission Rate Reduction: LNT treatment reduced the aerosol transmission rate from 100% (9/9 hamsters) to 44.4% (4/9 hamsters).
- Viral Shedding: LNT significantly reduced viral shedding in nasal washes and shortened its duration from approximately 6 days to 4 days.
- Respiratory Viral Loads: Viral loads in nasal turbinates, trachea, and lungs were significantly lower in LNT-treated hamsters compared to controls.
- Exhaled Aerosol Concentration: The average concentration of exhaled viral aerosols was significantly lower in LNT-treated hamsters throughout the disease progression.
- Aerodynamic Diameter Impact: The amount of virus-laden particles with aerodynamic diameters less than 5 µm showed a significant decreasing trend following LNT treatment.
- Infectious Virus Detection: The detection rate of infectious SARS-CoV-2 in smaller aerosol size fractions (e.g., >1.1 µm) was reduced in the LNT group compared to the placebo group.
Limitations and Future Work
The authors acknowledge two main limitations:
- Therapeutic vs. Prophylactic Efficacy: This study focused solely on the therapeutic effects of LNT after viral infection. The efficacy of LNT as a prophylactic agent (i.e., administered before infection) was not evaluated.
- Airborne Transmission Focus: The study exclusively examined the impact of LNT on airborne transmission. Other transmission routes, such as direct contact and fecal-oral transmission, were not investigated.
Future research should focus on:
- Prophylactic Efficacy: Investigating whether LNT can prevent infection or reduce transmission when administered before exposure.
- Other Transmission Routes: Exploring LNT's impact on contact and fecal-oral transmission of SARS-CoV-2.
- Mechanism Elucidation: Conducting in-depth studies to fully understand the specific molecular and cellular mechanisms by which LNT exerts its antiviral and transmission-reducing effects.
- Clinical Translation: Further preclinical studies are needed to substantiate these findings and pave the way for potential clinical trials in human COVID-19 patients.
Summary updated